Skip to content

Study of the pH profile in the human gastrointestinal tract, using an ingestible electronic device: the iPill

Study of the pH profile in the human gastrointestinal tract, using an ingestible electronic device: the iPill - Clinical study with iPill

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34774
Enrollment
10
Registered
2010-06-04
Start date
2010-07-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small bowel disorders normal values temperature and pH digestive tract

Interventions

None listed

Sponsors

Philips
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers 18-55 yr old Informed consent Weight less than 100 kg.

Exclusion criteria

Exclusion criteria: Subjects with known or suspected gastrointestinal strictures, including (suspected) Crohn*s disease Subjects with pacemakers or other implanted electro-medical devices Subjects with swallowing disorders Pregnancy (females) or unwillingness to institute anticonceptive measures (males and females) until > 1 month after study termination Subjects using acid reducing medication Subjects using NSAID* s Subject with known cardiopulmonary or any other gastrointestinal disorders Subjects with ASA > 1

Design outcomes

Primary

MeasureTime frame
Safety: * recording any signs of iPill retention, gastrointestinal bleeding or perforation * studying structural and functional integrity of the iPIll after gastrointestinal passage

Secondary

MeasureTime frame
Recording of pH, temperature and time during the iPill*s passage through the gastrointestinal tract (max 26 hrs). Testing two way communications: sending pH/temperature/time data to a remote data recorder worn on the subject*s body and receiving a signal to reprogram the iPill*s behaviour reducing the pH/temperature sampling frequency.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)